Chronic Obstructive Pulmonary Disease (COPD) is a progressive and debilitating respiratory disease affecting millions of individuals worldwide.
Cases of COPD Reported Annually2 (1990-2019)
Global Prevalence of COPD3
Leading Cause of Death Globally4
People Die from COPD Each Year5
If patients are diagnosed with COPD and subsequently emphysema, it may have a serious impact on a patient’s quality of life. However, standard medical care and oxygen treatments often become ineffective over time, leading to a need for innovative new therapies.1
The Spiration Valve System is an innovative endobronchial technology that offers patients with severe emphysema a customized, minimally invasive treatment option for bronchoscopic lung volume reduction (BLVR) with a favorable risk-benefit profile.1
It is a one-way valve that, once inserted into the airways, redirects air from diseased parts of the lungs to healthier parts. The procedure enables trapped air in a diseased lobe to escape around the valve, reducing the volume of the targeted lobe, which allows healthier parts of the lung to expand.
Randomized, controlled clinical trials demonstrate the Spiration Valve System is a safe and effective treatment option for patients with severe emphysema and little-to-no collateral ventilation.1
The umbrella-shaped design of the Spiration Valve redirects air from diseased parts of the lung to healthier parts while allowing trapped air and secretions to escape naturally along the airway wall so that patients may breathe easier.
*A negative change in SGRQ represents an improvement in disease-specific health status. A 4-point reduction is considered clinically meaningful.
**Target Lobe Volume Reduction data was published in the 12 month EMPROVE paper, but the data is actually 6 month data.
Potential complications which may be associated with bronchoscopy and/or the SpirationTM Valve System may include, but are not limited to, pneumothorax, worsening of COPD symptoms, pneumonia, dyspnea and in rare cases, death. Prior to using the Spiration Valve System, please review the full list of prescriptive information at https://svs.olympusamerica.com/prescriptive-information for additional information on indications, contraindications, warnings, precautions and potential complications.
Locate a SpirationTM Valve System Physician near them.
Locate a Spiration Valve System physician near them.
“A few days afterwards, I started feeling normal again, like a mother, a grandmother, and just getting back to doing things that I love to do.”
– Marion, Real Spiration Valve System Patient
Individual Results May Vary
“I can walk up the stairs, and I’m not out of breath so frequently. I had a major improvement on my life.”
– Ronny, Real Spiration Valve System Patient
Individual Results May Vary
A Decade of Clinical Experience
The SpirationTM Valve System has been available in the US Market since 2008 under a Humanitarian Device Exemption for the management of post-surgical prolonged air leaks.* Since its PMA approval in 2018, physicians continue to choose the Spiration Valve System for emphysema treatment because of their trust and familiarity with the product after clinical practice with air leaks, paired with the safety profile and broad valve size offering.
“I choose the Spiration Valve System because I have experience with it. I know how it works, how to deploy it, how it sits, and how to take it out, if necessary.”
– Jason A. Stienecker, DO
*Humanitarian Use Device. Authorized by Federal law for use in the control of prolonged air leaks of the lung, or significant air leaks that are likely to become prolonged air leaks, following lobectomy, segmentectomy, or Lung Volume Reduction Surgery (LVRS). The effectiveness of this device for this use has not been demonstrated.
Confidence in Valve Placement
The SpirationTM Valve System is intended to provide flexibility for airway deployment. The anchors were designed to allow valve placement independent of airway depth or access to a carina. This valve design allows for minimal contact with the bronchial wall while allowing the valve to remain securely positioned to redirect airflow in complex airways. In addition, the removal rod is designed to support removal if needed.
“I really appreciate the elegance and the design of the Spiration Valves.”
– Kirk G. Voelker, MD
Jason A. Stienecker, DO, and Kirk G. Voelker, MD, are paid consultants of Olympus Corporation of the Americas, its subsidiaries and/or its affiliates.
Potential complications which may be associated with bronchoscopy and/or the Spiration Valve System may include, but are not limited to, pneumothorax, worsening of COPD symptoms, pneumonia, dyspnea and in rare cases, death. Prior to using the Spiration Valve System, please review the full list of prescriptive information at https://svs.olympusamerica.com/prescriptive-information for additional information on indications, contraindications, warnings, precautions and potential complications.
Recommended by GOLD
The Spiration ValveTM System received an Evidence A Rating from the Global Initiative for Chronic Obstructive Lung Disease (GOLD)6, affirming that endobronchial valves are a viable minimally invasive treatment option for severe emphysema.
Trust your patients with COPD to a SpirationTM Valve System specialist for your patients.
Locate a Spiration Valve System physician near them.